Analysis by Quest Diagnostics of 2.5 million test results finds about half of patients of all ages are taking opioids and other potentially addictive medications inappropriately.
Submission to accelerate adoption of new point-of-care cell thawing technology.
Accreditor offers recommendations for how laboratories can help meet study goals.
Designed to minimize hands-on time and reduce the risk of cross contamination associated with manual sample handling, the module automates several processing steps.
DNA library preparation reagents from Kapa Biosystems have been incorporated into the GemCode platform from10X Genomics, making possible a more streamlined workflow for generating high-quality sequencing data.
Compact size makes the hoods suitable for student workstations and additional hood applications with limited space availability.
Providing the creamatocrit measure of mother’s milk, the analyzer is particularly useful in neonatal intensive care units to ensure that premature infants are receiving the calories they need to thrive.
Rather than applying a full-well coating of antibody, the plate wells are precision spotted with small droplets of the same antibody arranged in an array format.
New toxicology and pharmacogenomics capabilities facilitate the addition of genomic-based testing to more conventional practice portfolios.
The pair’s first project is to develop comprehensive panels to profile infectious diseases.
Contract for prenatal diagnostic testing services brings the number of covered lives under agreement for Sequenom Laboratories’ diagnostic services to more than 200 million.
The 500ºF electrically heated, Class 100 cleanroom oven supports such heat processes as sterilizing, depyrogenation, curing, and drying workloads.
According to a report by Transparency Market Research, the global market for molecular diagnostics is expected to achieve a CAGR of 11.1% from 2013 to 2019.
Clinical data show the utility of Biocept’s liquid biopsy assay in therapeutic management of patients with non-small cell lung cancer.
The standalone instrument enables rapid and safe identification, decapping, and recapping of up to 900 tubes per hour.
The Cobas Liat test is the first CLIA-waived real-time polymerase chain reaction test to detect influenza A and B in approximately 20 minutes.
Researchers from Sandia National Laboratories join with international experts to publish the first how-to book on laboratory biorisk management.
NIAID study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Study highlights the speed and reliability of a new sample protocol for biomarker development.
The NGAL protein has been designed to provide a high level of purity that minimizes the risk of interferences due to contaminants.